Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisugabalin for chronic kidney disease-associated pruritus in hemodialysis patients
ChiCTR2600118120Phase 4Not yet recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of crisugabalin besilate in chronic kidney disease (CKD), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoint: Worst Itch Numeric Rating Scale (WI-NRS). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2600118120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118120.